Cefepime

• Clinical impact of pharmacokinetic monitoring of antibiotics in critically ill patients Pending
  2023-504480-17-00 Phase IV 1 country Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
• Osteoarticular infections on prosthesis: impact of three antibiotic therapies on the digestive microbiota Pending
  2024-513298-29-00 Phase II 1 country Centre Hospitalier Universitaire De Nice
• BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis Pending
  2024-516849-39-01 Phase III 1 country Assistance Publique Hopitaux De Paris
• Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Pending
  2025-524264-38-00 Phase IV 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
• Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting
  2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted a… Recruiting
  2023-508442-18-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• PHARMACOKINETICS OF CEFEPIME AFTER INTRAPERITONEAL ADMINISTRATION VIA CYCLER-THERAPY IN APD PATIENTS WITHOUT PERITONITIS Ended
  2023-509930-21-00 Phase IV 1 country Noe LGA Gesundheit Region Mitte GmbH
• SAFE study: Stopping Antibiotics after 3 days for the treatment of FEbrile Neutropenia in Haematology patients, a randomized open-label non-… Ended
  2022-500389-84-00 Phase IV 1 country UZ Leuven
• COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended
  2023-505108-52-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complic… Ended
  2024-515180-56-00 Phase III 7 countries Meiji Seika Pharma Co. Ltd.
• Study to Assess the Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in the Treatment of C… Ended
  2024-515463-55-00 Phase III 6 countries Meiji Seika Pharma Co. Ltd.

Showing 1–11 of 11 trials